Acquiring OCT technology in one way or another would certainly be a great addition to Revenio’s product portfolio. Don’t Thirona’s AI algorithms analyze specifically OCT images? So, Revenio currently owns the “intelligent brains,” but doesn’t own the “eye” used to take the OCT images. After this, they would have the entire value chain and the data it produces pretty well in-house. It’ll be interesting to see what happens. I’d imagine we won’t have to wait very long for any strategic moves. Hopefully 
8 Likes